ライフサイエンスコーパス: saline solution

1 leomycin (control mice were instilled with a saline solution).

2 e remainder of the session) or placebo (0.9% saline solution).

3 Then the specimens were rinsed in saline solution.

4 d puncture followed by the administration of saline solution.

5 close arterial injection of CO(2)-saturated saline solution.

6 ion followed by the administration of normal saline solution.

7 ion followed by the administration of normal saline solution.

8 t differ in HRs and LRs self-administering a saline solution.

9 atients, 98 (88%) were infused with DCLHb or saline solution.

10 s were to be infused with 500 mL of DCLHb or saline solution.

11 seen with the infusion of phylloquinone in a saline solution.

12 ATAGGCAAAAATGG) at various concentrations of saline solution.

13 by the substitution of Ba2+ for Ca2+ in the saline solution.

14 a regimen previously proved effective, or to saline solution.

15 dogs were reassigned to a course of bFGF or saline solution.

16 n the groups treated initially with bFGF and saline solution.

17 site in charge, and are bactericidal in zinc saline solution.

18 njection of 200 microliters of CO2-saturated saline solution.

19 ompared with a 2400-mosm/L (7.5%) hypertonic saline solution.

20 t value of 44 s-1 were measured at pH 7.5 in saline solution.

21 in all cell types in roots from the stagnant saline solution.

22 d dilution with less than or equal to 100 mL saline solution.

23 dual HCO3(-) in a nominally CO2/HCO3(-)-free saline solution.

24 ushed and stored in HTK-N, TiProtec, HTK, or saline solution.

25 , made by bubbling cigarette smoke through a saline solution.

26 intranasal ketamine hydrochloride (50 mg) or saline solution.

27 30 min incubation in Ca2+-free physiological saline solution.

28 , followed by administration of Herceptin or saline solution.

29 trol group, which were given an injection of saline solution.

30 form brain tissue when cultured in a simple saline solution.

31 observed until 90 mins after infusion of CO-saline solution.

32 ntrol mice underwent treatment with balanced saline solution.

33 rom venous catheters were reused to withdraw saline solution.

34 ous tests up to 170 h toward a wide range of saline solutions.

35 PR chips, allowing for bioaffinity assays in saline solutions.

36 of vein grafts in saline, blood, or buffered saline solutions.

37 pper and quinone species in circumneutral pH saline solutions.

38 to that of Ag/AgCl in physiological (0.14 M) saline solutions.

39 ward if rats are denied access to hypertonic saline solutions.

40 ing HU, rats increased their intakes of both saline solutions (0.9% NaCl (n= 11): control 7.8 +/- 3 m

41 the following treatment groups: 1) SRP plus saline solution; 2) SRP plus low-level laser therapy (LL

42 maximus muscle superfused with physiological saline solution (35 degrees C, pH 7.4; n >/= 5 per group

43 as exposed and superfused with physiological saline solution (35 degrees C; pH 7.4).

44 dal margin of the membrane preparation and a saline solution adjacent to the retinal pigment epitheli

45 ery 10 mins or L-NAME 10 mg/kg in 1 mL/kg of saline solution administered after each hemorrhage for a

46 sensor is alternately exposed to glucose and saline solutions; after each cycle, difference spectra r

47 Use of buffered saline solution also tended to be associated with a lowe

48 mer surface in an aqueous phosphate-buffered saline solution and allowing the peptide solution to dry

49 stable colloids, is stable in physiological saline solution and cell culture media, and is not cytot

50 o 144 cells/mm2 in the animals that received saline solution and glucose solution, respectively (p =

51 rent concentrations of contrast material and saline solution and injected through various microcathet

52 ction limits at or below 1 ng/mL in buffered saline solution and spiked cell culture medium (CCM) has

53 ts for the monitoring of cytokines in spiked saline solutions and CCM were similar for TNF-alpha and

54 upled receptor (including benign aqueous and saline solutions and in the presence of dodecylphosphoch

55 -41 ((68)Ga-NOTA-UBI29-41) was formulated in saline solution, and 101 +/- 41 MBq were administered in

56 ver, the gluten became soluble in an aqueous saline solution, and it was not possible to isolate it u

57 was then placed into both eyes, rinsed with saline solution, and scanned at 5, 10, 15, and 30 min.

58 vailability of i.v. cocaine vs. nonrewarding saline solution, and then placed on extinction condition

59 (SRP) and local irrigation with physiologic saline solution; and 3) SRP/SA group (n = 30), SRP and l

60 at 15 and 30 mins when compared with normal saline solution animals (PaO2 -4% vs. -44%, peak airway

61 in bronchoalveolar lavage fluid from normal saline solution animals at any time.

62 When suspensions of the loaded materials in saline solution are exposed to low-power (10-100 mW) vis

63 shock and multiple-system trauma, hypertonic saline solutions are increasingly being used perioperati

64 es with a prototype microchip using gold and saline solution as a model electrode material and releas

65 gel-filtration column and phosphate buffered saline solution as the mobile phase.

66 ell-stirred and quiescent phosphate-buffered saline solutions as well as in a 0.3% agar solution.

67 during superfusion with bicarbonate-buffered saline solution at 34-36 C.

68 Potentiodynamic measurements, carried out in saline solution at body temperature, showed that the Ti-

69 ain of the MSCRAMMs, in a phosphate-buffered saline solution at neutral pH, were characteristic of a

70 when they are stored in a phosphate-buffered saline solution at pH 7.4.

71 With a saline solution at physiological pH, an Arixtra molecule

72 omized to receive either glucose solution or saline solution before the induced injury and the sham i

73 Mitomycin-C (MMC) and balanced saline solution (BSS) treatment acted as positive and ne

74 Physiologic saline solution (BSS; Alcon, Ft. Worth, TX) was injected

75 across the cortex in roots from the aerated saline solution but was relatively high in all cell type

76 eptides are immunogenic when administered in saline solution by either subcutaneous or intranasal rou

77 ry electrolytes and responses to infusion of saline solutions can distinguish between syndrome of app

78 rent doses of carbon monoxide (CO)-saturated saline solutions (CO-saline) affect microvascular and sy

79 ed with a negative unconditioned stimulus of saline solution, cockroaches conditioned in the early su

80 PTA per minute in a pH 7.40 phosphate buffer saline solution containing 10% dimethyl sulfoxide (DMSO)

81 esthesia, live bacteria suspended in a 30-mL saline solution containing 2-5 x 10(11) colony-forming u

82 ng catheter, the infusion of a physiological saline solution containing 4% BSA resulted in a marked n

83 RNS60 is a 0.9% saline solution containing charge-stabilized nanostructu

84 A tube with flowing saline solution containing contrast agent was positioned

85 A single subretinal injection of saline solution containing fluorescent beads caused a hi

86 HEPES-buffered physiological saline solution containing pEGFP plasmid at a low concen

87 ructure and salt retention of ice grown from saline solutions containing EPS from a culture of the se

88 /wt ethanol solution (ethanol group) or 0.9% saline solution (control group) at the end of DC inserti

89 oups of six rats with HCC were injected with saline solution (control group); CA4P, Dox-loaded PEG-co

90 ity of phenanthrene (chemical stress), while saline solutions controlled the water activity (drought

91 ham laparotomy and intrasplenic injection of saline solution; CsA given alone to dalmatians did not m

92 d to each of the following treatment groups: saline solution, dexamethasone sodium phosphate, a nonpa

93 8 (17%) of the 46 patients infused with the saline solution died (P = .003).

94 7 (15%) of the 46 patients infused with the saline solution died (P = .01).

95 of contrast material pushed with injectable saline solution during thoracic computed tomography (CT)

96 In general, concentrated saline solutions elicit robust behavioural aversion, whe

97 ced unilaterally, by injection of hypertonic saline solution, episcleral vein cauterization, or optic

98 tion of administration and to high volume of saline solution for dilution.

99 RNS60 is a 0.9% saline solution generated by subjecting normal saline to

100 kg daily on 2 consecutive days), or placebo (saline solution given in the same manner as IVIG).

101 rway pressure 28% vs. 69% at 30 mins; normal saline solution group vs. human gastric juice group, p <

102 2 +/- 0.5 vs. 6.4 +/- 0.4 at 60 mins, normal saline solution group vs. human gastric juice group, p =

103 and five of eight animals at 60 mins (normal saline solution group vs. human gastric juice group; p <

104 ns (human gastric juice group, n = 8; normal saline solution group, n = 4) postaspiration.

105 ns (human gastric juice group, n = 8; normal saline solution group, n = 4), 30 mins (human gastric ju

106 ns (human gastric juice group, n = 8; normal saline solution group, n = 4), or 60 mins (human gastric

107 rmal saline solution (pH 5.2 +/- 0.2; normal saline solution group; n = 12).

108 isulfite-free IPH 1.5% (group 1) or balanced saline solution (group 2) at the start of surgery.

109 C) storage in either buffered physiological saline solution (group 2) or UW solution (group 3).

110 comparison with control arteries exposed to saline solution (group 2).

111 ose vein grafts were preserved in a buffered saline solution had lower VGF rates and trends toward be

112 with laryngomalacia, application of a normal saline solution had no effect on the laryngomalacia scor

113 addition of steroids and anesthetics to the saline solutions had no impact on the signal intensity c

114 luctuating concentration of ascorbic acid in saline solution has been confirmed.

115 h medium for 3 days and with Hanks' buffered saline solution (HBSS) for 4 hours.

116 own to confluence, washed in Hank's balanced saline solution (HBSS), and then cultured for 72 hours i

117 ave ascorbic acid administered alone or with saline solution hydration.

118 ion followed by the administration of normal saline solution (i.e., fluid resuscitation).

119 ion followed by the administration of normal saline solution (i.e., fluid resuscitation).

120 ion followed by the administration of normal saline solution (i.e., fluid resuscitation).

121 ion followed by the administration of normal saline solution (i.e., fluid resuscitation).

122 ects during the "placebo" infusion (isotonic saline solution) immediately preceding the lactate infus

123 ogs, resuscitation was performed with normal saline solution in a volume equal to the total volume of

124 allenge with antigen in one segment and with saline solution in another.

125 th 90 mM Ba2+ in the pipette and physiologic saline solution in the bath.

126 digo carmine (0.05 mg/mL diluted in balanced saline solution) in the presence of high-brightness xeno

127 detection of urea between 78muM and 20mM in saline solution, in sample volumes of just 50muL.

128 eptides in 0.14 M NaCl/10 microM ZnCl2 (zinc saline solution) induced killing of P. haemolytica and o

129 e intracameral antibiotics (via the balanced saline solution infusion), and postoperative impregnated

130 , and injection of intact cells suspended in saline solution), injection of lysed blood provided the

131 erformed with injection of 10 ml of agitated saline solution into branch pulmonary arteries.

132 Control mice received saline solution intratracheally (0.05 mL, pulmonary cont

133 Control mice (Healthy) received saline solution intratracheally (Cp) or intraperitoneall

134 eparin/protamine titrations in physiological saline solutions is demonstrated.

135 The dye, dissolved in normal saline solution, is added to a chamber containing the pr

136 in response to 51 mM potassium physiological saline solution (KCl).

137 3 mm HCO3(-) to an O2-gassed, HEPES-buffered saline solution lowered the intracellular H(+) concentra

138 omized trials have suggested that hypertonic saline solutions may be superior to mannitol for the tre

139 between the LODs of the GeneXpert assay with saline solution (median, 33 CFU/ml) and CSF (median, 25

140 her 1.25 g/kg ioxilan (n = 10) or hypertonic saline solution (n = 10) as a control.

141 nd atherosclerotic mice were injected with a saline solution (n = 2).

142 8 mug/2 muL of 6-hydroxydopamine (n = 6) or saline solution (n = 4) in the right medial forebrain bu

143 olysates by means of alkaline-hydroalcoholic saline solutions (NaOH: 0.54 M, EtOH: 1.17 v, NaCl: 2.5%

144 method was validated with the blinded use of saline solutions of varying sodium concentrations.

145 ochloride (0.4 mg/kg), m-CPP (1.0 mg/kg), or saline solution on 3 separate test days in a randomized

146 ors undergoing cardiac surgery and stored in saline solution on ice until transplantation.

147 Mice that received phosphate-buffered saline solution only were included as nonadoptive-transf

148 pproximately 18 mice, were fed either normal saline solution or 15 mg/kg fluvastatin for 15 days.

149 ere intravenously administered with either a saline solution or a recombinant human erythropoietin (5

150 ll inflated either by external injections of saline solution or air, or by internal osmotic pressure

151 nterval, type of contrast agent (eg, sterile saline solution or water), and quantity of contrast agen

152 ation can be altered via the electrolysis of saline solutions or deionized water.

153 ly elevated compared to that determined with saline solution (P </= 0.05 and </= 0.0005, respectively

154 yoglobin, and lysozyme as test proteins in a saline solution, passed through the SR, are demonstrated

155 human gastric juice group, n = 24) or normal saline solution (pH 5.2 +/- 0.2; normal saline solution

156 water-soluble chlorins in phosphate-buffered saline solution (pH 7.4) at room temperature were invest

157 hort echo times (0.4 msec) by using external saline solution phantoms for reference.

158 njection of 120 million Cx601 cells or 24 mL saline solution (placebo), with stratification according

159 ed when 40 mM KCl was added to physiological saline solution (PSS) (peak value assigned 100%), and th

160 Preincubating IPAs in physiological saline solution (PSS) containing 1 mm cysteine increased

161 nisolone, 0.025% doxycycline, or physiologic saline solution (PSS) four times per day.

162 gions, nine healthy women tasted an aversive saline solution, pure water and chocolate while rCBF was

163 sec) (23)Na images to those from an external saline solution reference.

164 t of cimetidine (cimetidine group [CimG]) or saline solution (sham group [SG]).

165 90% phenol (denervation group [PDN]) or 0.9% saline solution (sham-operated group [SHAM]).

166 line, addition of blood or plasma to the air-saline solution significantly increased the concentratio

167 After systemic administration of hypertonic saline solutions, significantly more water was consumed

168 0 min) incubation in Ca2+-free physiological saline solution similarly reduced phase 2 but abolished

169 After volume replacement with normal saline solution, SMV %HbO2 and flow were not significant

170 ipratropium bromide (84 microgram) or normal saline solution sprayed into the nasal cavity 15 min bef

171 uring stable bromine isotope compositions in saline solutions such as seawater, brines, and formation

172 e of extracellular Ca2+ and also in Na+-free saline solutions, suggesting that hyperpolarisation lead

173 3-phosphocholine lipid bilayers in different saline solutions, that ions can locally induce ordering

174 roup 1 (control): subcutaneous injections of saline solution, three times a week (n = 15); group 2: 2

175 ance, PBS = phosphate-buffered physiological saline solution, TMJ = temporomandibular joint, mu(T) =t

176 -STb-bound T84 and HT29 cells with an acidic saline solution to remove surface-bound toxin revealed t

177 two subconjunctival injections of DMSO or of saline solution to right eyes only or they remained untr

178 el), rats were IV administered with either a saline solution (traumatic brain injury-saline group) or

179 ne hydrochloride (0.1 mg/kg or 0.5 mg/kg) or saline solution under randomized double-blind conditions

180 le injection of depot medroxyprogesterone or saline solution was administered.

181 Balanced saline solution was injection into the left eye of each

182 recovery, 10 mL/kg of 20% meconium in normal saline solution was insufflated into the lungs.

183 emolytica incubated with H-DDDDDD-OH in zinc saline solution was killed within 30 min.

184 After 24 hours, the protein content of the saline solution was measured by standard assay and perme

185 re, glycine (0.6 mmol/kg) or vehicle (normal saline solution) was administered intravenously over 15

186 Sialidase (or saline solution) was infused to the injury site continuo

187 n dose injected into young outbred mice as a saline solution, were bactericidal against B. pertussis,

188 etection limit of 0.005 unit/mL heparin in a saline solution, which is slightly lower than the detect

189 ed by supplementing the bicarbonate-buffered saline solution with HEPES.

190 the 1a film was found in phosphate-buffered saline solution with TPrA.

191 1 is designed to be unstructured in buffered saline solution, yet undergo HA-induced folding that is